Inventor · Los Angeles, CA, US

David S. Eisenberg

20Patents
9h-index
32Co-inventors
75Inventor score

Filing activity: Mar 28, 1994 → May 26, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US5917017A Diphtheria toxin vaccines bearing a mutated R domain Chemistry; Metallurgy 57 Expired
US5843711A Diphtheria toxin receptor-binding region Chemistry; Metallurgy 55 Expired
US5436850A Method to identify protein sequences that fold into a known three-dimensional structure Physics 43 Expired
US6093573A Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) Emerging Cross-Sectional Technologies 33 Expired
US7125680B2 Methods and materials for characterizing and modulating interaction between heregulin and HER3 Physics 22 Expired
US6892139B2 Determining the functions and interactions of proteins by comparative analysis Physics 20 Expired
US6564151B1 Assigning protein functions by comparative genome analysis protein phylogenetic profiles Physics 12 Expired
US6466874B1 Rosetta stone method for detecting protein function and protein-protein interactions from genome sequences Physics 11 Expired
US6772069B1 Determining protein function and interaction from genome analysis Physics 11 Expired
US7314916B2 Methods and materials for characterizing and modulating interaction between heregulin and HER3 Physics 6 Expired
US6512981B1 Protein fold recognition using sequence-derived predictions Physics 5 Expired
US7459439B2 Granulysin peptides and methods of use thereof Human Necessities 3 Active
US8754034B2 Structure-based design of peptide inhibitors of amyloid fibrillation Physics 1 Active
US9873718B2 Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics Chemistry; Metallurgy 1 Active
US10934332B2 Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment Physics 0 Active
US9463195B2 Dissolution of amyloid fibrils by flavonoids and other compounds Human Necessities 0 Active
US11390646B2 Structure-based peptide inhibitors of α-synuclein aggregation Physics 0 Active
US11028128B2 Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments Physics 0 Active
US10815271B2 Structure-based peptide inhibitors of alpha-synuclein aggregation Physics 0 Active
US10400010B2 Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.